THURSDAY, Sept. 16, 2021 (HealthDay News) — Even when genetics and personality are working against you, having a strong network of supportive friends and family may help lower alcoholism risk, researchers say. “Genes play an important role in alcohol use,” stressed Jinni Su, an assistant professor of psychology at ArizonaContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months, CBS News reported. Between June and August, about 287,000 people who were not vaccinated were hospitalized for COVID-19 in the United States, according to data fromContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — The number of U.S. infants born with syphilis is climbing at an alarming pace, reaching a high not seen since the 1990s, according to new government figures. Newborn syphilis, a potentially fatal condition, was at one time nearly eliminated in the United States.Continue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — It’s hard to resist those big, pleading eyes in the pet store window. But buyer beware. Pet store puppies may infect people with a bacteria for which no common antibiotic treatment exists, a new study warns. Campylobacter jejuni (C jejuni) cannot be treatedContinue Reading

TUESDAY, Sept. 14, 2021 (HealthDay News) — An experimental Ebola vaccine appeared effective in children and adults in a clinical trial. Two doses of Johnson & Johnson’s Ebola vaccine appear safe, well tolerated and produce a strong immune response in people over the age of 1, according to two just-publishedContinue Reading